218 related articles for article (PubMed ID: 25604078)
1. Targeting protein kinase C subtypes in pancreatic cancer.
Storz P
Expert Rev Anticancer Ther; 2015 Apr; 15(4):433-8. PubMed ID: 25604078
[TBL] [Abstract][Full Text] [Related]
2. Preclinical and clinical development of novel agents that target the protein kinase C family.
Serova M; Ghoul A; Benhadji KA; Cvitkovic E; Faivre S; Calvo F; Lokiec F; Raymond E
Semin Oncol; 2006 Aug; 33(4):466-78. PubMed ID: 16890801
[TBL] [Abstract][Full Text] [Related]
3. Classical PKC isoforms in cancer.
Martiny-Baron G; Fabbro D
Pharmacol Res; 2007 Jun; 55(6):477-86. PubMed ID: 17548205
[TBL] [Abstract][Full Text] [Related]
4. A small molecule inhibitor of atypical protein kinase C signaling inhibits pancreatic cancer cell transformed growth and invasion.
Butler AM; Scotti Buzhardt ML; Erdogan E; Li S; Inman KS; Fields AP; Murray NR
Oncotarget; 2015 Jun; 6(17):15297-310. PubMed ID: 25915428
[TBL] [Abstract][Full Text] [Related]
5. Protein kinase D enzymes: novel kinase targets in pancreatic cancer.
Liou GY; Storz P
Expert Rev Gastroenterol Hepatol; 2015; 9(9):1143-6. PubMed ID: 26174103
[TBL] [Abstract][Full Text] [Related]
6. New paradigms in anticancer therapy: targeting multiple signaling pathways with kinase inhibitors.
Faivre S; Djelloul S; Raymond E
Semin Oncol; 2006 Aug; 33(4):407-20. PubMed ID: 16890796
[TBL] [Abstract][Full Text] [Related]
7. Protein kinase C: a target for therapy in pancreatic cancer.
El-Rayes BF; Ali S; Philip PA; Sarkar FH
Pancreas; 2008 May; 36(4):346-52. PubMed ID: 18437080
[TBL] [Abstract][Full Text] [Related]
8. PKD at the crossroads of DAG and PKC signaling.
Wang QJ
Trends Pharmacol Sci; 2006 Jun; 27(6):317-23. PubMed ID: 16678913
[TBL] [Abstract][Full Text] [Related]
9. Discovery of a novel class of targeted kinase inhibitors that blocks protein kinase C signaling and ameliorates retinal vascular leakage in a diabetic rat model.
Grant S; Tran P; Zhang Q; Zou A; Dinh D; Jensen J; Zhou S; Kang X; Zachwieja J; Lippincott J; Liu K; Johnson SL; Scales S; Yin C; Nukui S; Stoner C; Prasanna G; Lafontaine J; Wells P; Li H
Eur J Pharmacol; 2010 Feb; 627(1-3):16-25. PubMed ID: 19850035
[TBL] [Abstract][Full Text] [Related]
10. The role of p21-activated kinases in pancreatic cancer.
Yeo D; He H; Baldwin GS; Nikfarjam M
Pancreas; 2015 Apr; 44(3):363-9. PubMed ID: 25760284
[TBL] [Abstract][Full Text] [Related]
11. Protein kinase Cs in lung cancer: a promising target for therapies.
Fan C; Li Y; Jia J
J Cancer Res Ther; 2013 Sep; 9 Suppl 2():S74-9. PubMed ID: 24135246
[TBL] [Abstract][Full Text] [Related]
12. PKC-delta and -epsilon regulate NF-kappaB activation induced by cholecystokinin and TNF-alpha in pancreatic acinar cells.
Satoh A; Gukovskaya AS; Nieto JM; Cheng JH; Gukovsky I; Reeve JR; Shimosegawa T; Pandol SJ
Am J Physiol Gastrointest Liver Physiol; 2004 Sep; 287(3):G582-91. PubMed ID: 15117677
[TBL] [Abstract][Full Text] [Related]
13. Competitive inhibitors and allosteric activators of protein kinase C isoenzymes: a personal account and progress report on transferring academic discoveries to the clinic.
Budas GR; Koyanagi T; Churchill EN; Mochly-Rosen D
Biochem Soc Trans; 2007 Nov; 35(Pt 5):1021-6. PubMed ID: 17956268
[TBL] [Abstract][Full Text] [Related]
14. Targeting the oncogenic protein kinase Ciota signalling pathway for the treatment of cancer.
Fields AP; Frederick LA; Regala RP
Biochem Soc Trans; 2007 Nov; 35(Pt 5):996-1000. PubMed ID: 17956262
[TBL] [Abstract][Full Text] [Related]
15. Neurotensin induces protein kinase C-dependent protein kinase D activation and DNA synthesis in human pancreatic carcinoma cell line PANC-1.
Guha S; Rey O; Rozengurt E
Cancer Res; 2002 Mar; 62(6):1632-40. PubMed ID: 11912133
[TBL] [Abstract][Full Text] [Related]
16. The pros and cons of targeting protein kinase C (PKC) in the management of cancer patients.
Leskow FC; Krasnapolski MA; Urtreger AJ
Curr Pharm Biotechnol; 2011 Nov; 12(11):1961-73. PubMed ID: 21470133
[TBL] [Abstract][Full Text] [Related]
17. PKC inhibitors: potential in T cell-dependent immune diseases.
Baier G; Wagner J
Curr Opin Cell Biol; 2009 Apr; 21(2):262-7. PubMed ID: 19195860
[TBL] [Abstract][Full Text] [Related]
18. A novel small-molecule inhibitor of protein kinase Ciota blocks transformed growth of non-small-cell lung cancer cells.
Stallings-Mann M; Jamieson L; Regala RP; Weems C; Murray NR; Fields AP
Cancer Res; 2006 Feb; 66(3):1767-74. PubMed ID: 16452237
[TBL] [Abstract][Full Text] [Related]
19. Protein kinase C inhibitors: a patent review (2008 - 2009).
Sobhia ME; Grewal BK; Ml SP; Patel J; Kaur A; Haokip T; Kokkula A
Expert Opin Ther Pat; 2013 Oct; 23(10):1297-315. PubMed ID: 23795914
[TBL] [Abstract][Full Text] [Related]
20. Directed modulation of protein kinase C isozyme selectivity with bisubstrate-based inhibitors.
van Wandelen LT; van Ameijde J; Mady AS; Wammes AE; Bode A; Poot AJ; Ruijtenbeek R; Liskamp RM
ChemMedChem; 2012 Dec; 7(12):2113-21. PubMed ID: 23139239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
